Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Trial of Leflunomide in Women With Previously Treated Metastatic Triple Negative Cancers

NCT03709446 is registered in ClinicalTrials.gov with Joseph Sparano as lead sponsor.

NCT NCT03709446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03709446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Trial of Leflunomide in Women With Previously Treated Metastatic Triple Negative Cancers
Lead sponsor
Joseph Sparano
Phase
Phase 1/2
Overall status
Completed
Start date
April 16, 2019
Completion date
November 27, 2025
Enrollment
17 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast diseases, breast neoplasms, metastatic triple negative breast cancer